Serum sodium predicts mortality in patients listed for liver transplantation. - Wikidata - wikimedia - TriplyDB

Serum sodium predicts mortality in patients listed for liver transplantation.

Serum sodium predicts mortality in patients listed for liver transplantation.

http://www.wikidata.org/entity/Q44642186

about

Advances in liver transplantation allocation systems Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation.Prognostic performance of a series of model for end-stage liver disease and respective Δ scores in patients with hepatitis B acute-on-chronic liver failure.Impact of pretransplant hyponatremia on outcome following liver transplantation.Stage of cirrhosis predicts the risk of liver-related death in patients with low Model for End-Stage Liver Disease scores and cirrhosis awaiting liver transplantation Systematic review: The model for end-stage liver disease--should it replace Child-Pugh's classification for assessing prognosis in cirrhosis?Mortality after hospitalization with mild, moderate, and severe hyponatremia.Mortality associated with low serum sodium concentration in maintenance hemodialysis.Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.Hyponatremia influences the outcome of patients with acute-on-chronic liver failure: an analysis of the CANONIC study Plasma fibroblast growth factor 23 concentration is increased and predicts mortality in patients on the liver-transplant waiting list.Hyponatremia and mortality among patients on the liver-transplant waiting list Profile of hepatic encephalopathy in children with cirrhosis and response to lactulose.MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation Serum sodium, renal function, and survival of patients with end-stage liver disease.Impact of MELD Allocation System on Waiting List and Early Post-Liver Transplant Mortality.Improving survival in decompensated cirrhosis Liver transplantation in adults: Choosing the appropriate timing Model for end-stage liver disease: end of the first decade.Kidney, pancreas and liver allocation and distribution in the United States Moderate hyperkalemia in hospitalized patients with cirrhotic ascites indicates a poor prognosis.Using an Electronic Medical Records Database to Identify Non-Traditional Cardiovascular Risk Factors in Nonalcoholic Fatty Liver Disease.Current Status of Liver Allocation in the United States Evaluation of a scoring system for assessing prognosis in pediatric acute liver failure.Evaluation and management of patients with refractory ascites.Alkaline phosphatase: the next independent predictor of the poor 90-day outcome in alcoholic hepatitis Development of a survival evaluation model for liver transplant recipients with hepatocellular carcinoma secondary to hepatitis B.Diagnosis and management of hyponatremia in acute illness Ascites improves upon [corrected] serum sodium plus [corrected] model for end-stage liver disease (MELD) for predicting mortality in patients with advanced liver disease.Impact of pretransplant hepatic encephalopathy on liver posttransplantation outcomes.New model for end stage liver disease improves prognostic capability after transjugular intrahepatic portosystemic shunt.Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine.Overview of the indications and contraindications for liver transplantation.Accuracy of MELD scores in predicting mortality in decompensated cirrhosis from variceal bleeding, hepatorenal syndrome, alcoholic hepatitis, or acute liver failure as well as mortality after non-transplant surgery or TIPS.Hyponatremia in hospitalized patients: the potential role of tolvaptan.Hyponatraemia: more than just a marker of disease severity?Important predictor of mortality in patients with end-stage liver disease.Tolvaptan for the treatment of liver cirrhosis oedema.Role of vaptans in the management of hydroelectrolytic imbalance in liver cirrhosis.Employment of vasopressin receptor antagonists in management of hyponatraemia and volume overload in some clinical conditions.

P2860

Q26766076-F1FA45E3-972A-4621-9C9F-D7CD3AFBFEA0 Q33506549-FEF177E3-7484-40A7-9FCE-17E5F65AD546 Q33608736-7513C732-5F78-4B09-8BF1-671DCA77F239 Q33989198-1F185926-7B10-42CE-B11C-D6E20724D91D Q34254341-10BAE979-C5ED-42D4-BA40-34CDC6F83114 Q34469838-5C1D2D01-F8FE-4E5C-978F-80B7E344512C Q34551988-1E4D5C2F-959F-4DE3-84D5-813F67A823D3 Q34580775-60081A5C-D4E3-471A-AE89-3363E65B6D9F Q34678891-435C436C-2118-41A6-B6DE-64AF6C7D9CA3 Q34789475-83C46455-1350-431C-8C4A-618532178540 Q34794004-77B1812B-E26E-46A6-94C0-70869BB94124 Q34820619-567D3613-E993-41D8-8413-C0EFF22E1E55 Q34996031-A24861BB-976C-43A5-A3DB-16A79A648E5A Q35954077-CD414AB4-65AC-47DF-8653-7DA5C40724EC Q35988332-AC9A1E04-4121-418C-9F62-13230AC9CD74 Q36051596-11E54A78-3D3D-463C-BE9E-F46AF2D5BD42 Q36090423-09994282-63FB-42B7-9A02-596212892274 Q36220176-74E12C40-0862-4D22-AA91-5F6AD0B4F6AC Q36588122-BCDA2FD5-2804-48E3-91D8-520026B41F08 Q36591435-85122D2D-21C3-4C8E-8407-54D552578D4A Q36634933-5316C712-8194-4E2A-899D-D32C25B730FB Q36892592-6A5DBA4D-47F4-4999-94B0-3A870C9B7E8B Q36916627-80F36B03-036C-4FE5-B87A-DA2D283F2E7B Q36969100-998F994C-A583-478F-B018-A19DE5937703 Q37122130-74C48847-C590-4B7C-A00A-8DD70684FC88 Q37212281-72540ECE-ACCD-4985-A838-2629DE2CC45E Q37212974-B6A80DC6-77FA-46D4-9FE9-B50A4AA4B2DF Q37277688-41B44F88-F6D1-4B08-868A-7D408A4D344F Q37343682-B568FD13-6C4E-4267-8E91-2CEF66EE9C7E Q37353473-863C4760-A9E9-4A78-BE9A-101E260F25FF Q37438532-DE39C1EF-D91C-4D91-A67F-4BA6645CDF37 Q37636499-6C24AB82-6982-4913-91FA-5A0CF1F2ABB7 Q37717937-7FE46BD9-655C-4440-B275-1C3F291666AA Q37789176-56EE6E13-8892-43D9-AF81-3CADBB4C92E3 Q37924510-4E6FAF60-B79E-4CDE-BD77-E4227CA99CCA Q38061001-2AD82B50-A6D4-441C-AADC-D623F17B7AF1 Q38120248-C7A62ADD-F800-4F96-BA93-707ADDDA3556 Q38200108-E425CD91-CB58-4F32-8DE9-15A374DA3D87 Q38271966-15FE732D-CE59-4803-B770-7C26A4EF0545 Q38449311-E18B6B89-5FE8-4786-9E8A-CEA0D27E45CE

P2860

Serum sodium predicts mortality in patients listed for liver transplantation.

http://www.wikidata.org/entity/Q44642186

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Serum sodium predicts mortality in patients listed for liver transplantation.

@en

Serum sodium predicts mortality in patients listed for liver transplantation.

@nl

type

label

Serum sodium predicts mortality in patients listed for liver transplantation.

@en

Serum sodium predicts mortality in patients listed for liver transplantation.

@nl

prefLabel

Serum sodium predicts mortality in patients listed for liver transplantation.

@en

Serum sodium predicts mortality in patients listed for liver transplantation.

@nl

P1433

Q44642186-46A075B9-A47D-4FFA-82AD-1585E369D442

P1476

Q44642186-2ADD5BA1-02BE-4AD0-83D9-834F228EFF1D

P2093

Q44642186-077E295A-DEDD-4603-AFCA-94CB011EEB1C

Q44642186-09759767-72FF-4F91-BFF5-9AFA0BC08B09

Q44642186-A1D107C8-0AA6-4473-BEFF-70874AE24941

Q44642186-D12D9C13-609D-4540-859E-A6AA91BEFBF2

Q44642186-D1EB3205-393F-4DB4-8ED3-3A9C36AA9E4C

Q44642186-FB5E9941-7A29-4D13-A087-2457136117FC

P2860

Q44642186-183A3CA6-9619-4A0A-ADF3-B5A926606AEA

P304

Q44642186-56E75EE6-FC97-411B-B61C-6043A7D6867F

P31

Q44642186-9C7D82B1-B9CB-41DC-AC48-656FCC267DED

P356

Q44642186-6E1846D8-BE06-445A-9476-1FB927EA2B2A

P407

Q44642186-4CECE191-4323-4AAE-8A10-9204F73C5881

P433

Q44642186-C7FB7B8C-98CF-46EF-B808-3749EEC55E2F

P478

Q44642186-6BC82E33-9D1C-40A5-90AE-67D2D508133D

P577

Q44642186-0BF401DC-7B26-48BA-B264-9CE9F89D0ABD

P5875

Q44642186-CECD4A3E-AAEA-4A2D-A838-7798CF443609

P698

Q44642186-96B3C709-C5A0-451D-96A6-F56C31C287DD

P921

Q44642186-F72BCEC6-BB05-4972-B432-0E7CEFBFCA23

P356

P1433

P1476

Serum sodium predicts mortality in patients listed for liver transplantation.

@en

P2093

Harry J Rodriguez

http://www.w3.org/2001/XMLSchema#string

John P Roberts

http://www.w3.org/2001/XMLSchema#string

Nathan M Bass

http://www.w3.org/2001/XMLSchema#string

Norah A Terrault

http://www.w3.org/2001/XMLSchema#string

Peter Bacchetti

http://www.w3.org/2001/XMLSchema#string

Scott W Biggins

http://www.w3.org/2001/XMLSchema#string

P2860

Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites.

P304

32-39

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.20517

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8043018

http://www.w3.org/2001/XMLSchema#string

P698

15690479

http://www.w3.org/2001/XMLSchema#string

P921

liver transplantation